• FR
  • Donate
  • About
    • What is ARSACS?
    • Our Mission
    • What We Do
    • Our Team
      • Founders
      • Board of Directors
      • Researchers
    • Privacy Policy
  • Persons with ARSACS
    • International Patient Registry
    • Frequently Asked Questions
    • Patient Participation
      • Research Study
    • Connect with ARSACS Community
    • ARSACS Exercise Program at Home
  • Research
    • Research Projects
    • Research Project Reports
    • Research Grants
    • Research Tools
    • Partnerships
    • Preclinical and Clinical Trials
    • Publications
  • How You Can Help
  • Conferences & Events
    • 2026 International ARSACS Symposium
  • News
  • Contact

Research Project Reports

Mar 31, 2026

Dimethyl Fumarate Tested in an ARSACS Mouse Model

Mar 31, 2026 | Research Project Reports

read more...

Developing conditional mouse models and new approaches to treating ARSACS – by Dr. Stefan Strack, University of Iowa Carver College of Medicine

Feb 1, 2026 | Research Project Reports

read more...

Towards glial-targeted therapies of ARSACS – by Drs Herrera/Fernandes/Adams, University of Lisbon / Bilkent University

Jan 8, 2026 | Research Project Reports

read more...
« Older Entries


Location

1000 Sherbrooke O, bur. 2100, Montréal, QC H3A 3G4



Contact

1 (514) 370-3625
ataxie@arsacs.com

Contact Ataxia Charlevoix-Saguenay Foundation

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Copyright © 2026, Ataxia Charlevoix-Saguenay Foundation, 856980321RR0001

  • Follow
  • Follow